📣 VC round data is live. Check it out!
- Public Comps
- SC Ropharma
SC Ropharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for SC Ropharma and similar public comparables like Farmacosmo, Pilulka Lekarny, Rise, PetMeds and more.
SC Ropharma Overview
About SC Ropharma
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
Founded
1952
HQ

Employees
1.3K
Website
Sectors
Financials (FY)
EV
$55M
Valuation Multiples
Start free trialSC Ropharma Financials
SC Ropharma reported last fiscal year revenue of $265M and EBITDA of $12M.
In the same fiscal year, SC Ropharma generated $37M in gross profit, $12M in EBITDA, and had net loss of ($383K).
SC Ropharma P&L
In the most recent fiscal year, SC Ropharma reported revenue of $265M and EBITDA of $12M.
SC Ropharma is unprofitable as of last fiscal year, with gross margin of 14%, EBITDA margin of 5%, and net margin of (0%).
Financial data powered by Morningstar, Inc.
SC Ropharma Stock Performance
SC Ropharma has current market cap of $23M, and enterprise value of $55M.
Market Cap Evolution
SC Ropharma's stock price is $0.04.
SC Ropharma share price decreased by 4.1% in the last 30 days, and increased by 19.9% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55M | $23M | 1.1% | -4.1% | -8.0% | 19.9% | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSC Ropharma Valuation Multiples
SC Ropharma trades at 0.2x EV/Revenue multiple, and 4.4x EV/EBITDA.
SC Ropharma Financial Valuation Multiples
As of May 26, 2026, SC Ropharma has market cap of $23M and EV of $55M.
SC Ropharma has a P/E ratio of (59.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SC Ropharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SC Ropharma Margins & Growth Rates
In the most recent fiscal year, SC Ropharma reported gross margin of 14%, EBITDA margin of 5%, and net margin of (0%).
SC Ropharma Margins
SC Ropharma Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SC Ropharma Operational KPIs
SC Ropharma's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
SC Ropharma Competitors
SC Ropharma competitors include Farmacosmo, Pilulka Lekarny, Rise, PetMeds, Talea Group, BlueMTec, d1000, MARX Biotech, Green Cross Health and Profarma.
Most SC Ropharma public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.3x | — | 23.8x | — | |||
| 0.3x | — | (8.1x) | — | |||
| 5.1x | 4.5x | 18.7x | — | |||
| 0.1x | 0.1x | 2.9x | (0.5x) | |||
| 0.6x | — | 24.4x | — | |||
| 0.6x | — | 92.0x | — | |||
| 0.3x | — | 3.8x | — | |||
| 5.1x | — | 35.6x | — | |||
This data is available for Pro users. Sign up to see all SC Ropharma competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SC Ropharma
| When was SC Ropharma founded? | SC Ropharma was founded in 1952. |
| Where is SC Ropharma headquartered? | SC Ropharma is headquartered in Romania. |
| How many employees does SC Ropharma have? | As of today, SC Ropharma has over 1K employees. |
| Is SC Ropharma publicly listed? | Yes, SC Ropharma is a public company listed on Bucharest Stock Exchange. |
| What is the stock symbol of SC Ropharma? | SC Ropharma trades under RPH ticker. |
| When did SC Ropharma go public? | SC Ropharma went public in 1997. |
| Who are competitors of SC Ropharma? | SC Ropharma main competitors include Farmacosmo, Pilulka Lekarny, Rise, PetMeds, Talea Group, BlueMTec, d1000, MARX Biotech, Green Cross Health, Profarma. |
| What is the current market cap of SC Ropharma? | SC Ropharma's current market cap is $23M. |
| What is the current revenue of SC Ropharma? | SC Ropharma's last fiscal year revenue is $265M. |
| What is the current EV/Revenue multiple of SC Ropharma? | Current revenue multiple of SC Ropharma is 0.2x. |
| Is SC Ropharma profitable? | No, SC Ropharma is not profitable. |
| How many companies SC Ropharma has acquired to date? | SC Ropharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies SC Ropharma has invested to date? | SC Ropharma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to SC Ropharma
Lists including SC Ropharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.